tolazoline has been researched along with Atrophy in 1 studies
Tolazoline: A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.
tolazoline : A member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schreyer, H | 1 |
| Schwarz, G | 1 |
| Kerl, H | 1 |
1 other study available for tolazoline and Atrophy
| Article | Year |
|---|---|
[Pharmaco-angiography with Priscolin in progressive scleroderma (author's transl)].
Topics: Adolescent; Adult; Aged; Arteries; Atrophy; Collateral Circulation; Edema; Female; Fingers; Hand; Hu | 1976 |